Evidence map›Paper›PMID 37592150›Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2023

Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.

Judith Everts-Graber, Harald Bonel, Daniel Lehmann, Brigitta Gahl, HansJörg Häuselmann, Ueli Studer, Hans-Rudolf Ziswiler, Stephan Reichenbach, Thomas Lehmann

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Judith Everts-GraberOsteoRheuma Bern AG, Bahnhofplatz 1, CH- 3011, Bern, Switzerland. judith.everts@hin.ch.ORCID http://orcid.org/0000-0002-8792-8199
Harald BonelCampus Stiftung Lindenhof Bern, Swiss Institute for Translational and Entrepreneurial Medicine, Bern, Switzerland.
Daniel LehmannFaculty of Medicine, University of Bern, Bern, Switzerland.
Brigitta GahlClinical Trial Unit, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0001-8123-0438
HansJörg HäuselmannZentrum Für Rheuma- Und Knochenerkrankungen, Klinik Im Park, Hirslanden Zurich, Switzerland.
Ueli StuderOsteoRheuma Bern AG, Bahnhofplatz 1, CH- 3011, Bern, Switzerland.
Hans-Rudolf ZiswilerOsteoRheuma Bern AG, Bahnhofplatz 1, CH- 3011, Bern, Switzerland.
Stephan ReichenbachDepartment of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0001-8098-6567
Thomas LehmannOsteoRheuma Bern AG, Bahnhofplatz 1, CH- 3011, Bern, Switzerland.ORCID http://orcid.org/0000-0003-0739-5562
University of Bern · CHBern University of Applied Sciences · CHHirslanden Klinik Im Park · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37592150
PMCPMC10579170
OpenAlexW4385902276

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.